Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Theravance, Inc.”

369 pharma patents match "Theravance, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 369
Index total 30,257
Page 6 / 16

Quick answer

This filtered view shows 369 pharmaceutical patents matching "Theravance, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

369 results for “Theravance, Inc.” · 30,257 patents in full index Clear search

  1. US 8084417

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  2. US 8080565

    Substituted 4-amino-benzylpiperidine compounds

    Theravance, Inc. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  3. US 8080572

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  4. US 8067439

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  5. US 8053448

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted

  6. US 8044195

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  7. US 8044045

    Indazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  8. US 8039489

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  9. US 8034946

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  10. US 8030445

    Glycopeptide derivative

    Theravance, Inc. · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  11. US 8030502

    Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds

    Theravance, Inc. · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  12. US 8017783

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  13. US 8017617

    Amidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  14. US 8013152

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  15. US 8013005

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  16. US 8008278

    Diarylmethyl and related compounds

    Theravance, Inc. · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  17. US 8003755

    Hydrochloride salts of a glycopeptide phosphonate derivative

    Theravance, Inc. · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  18. US 8003664

    Indazole-carboxamide compounds

    Theravance, Inc. · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  19. US 7994209

    3-phenoxymethylpyrrolidine compounds

    Theravance, Inc. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  20. US 7994165

    Aryl aniline derivatives as β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  21. US 7989484

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  22. US 7981931

    Pharmaceutical compositions of short-acting sedative hypnotic agent

    Theravance, Inc. · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  23. US 7964730

    Amino-substituted ethylamino β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted

  24. US 7960385

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.